피임기구 시장 규모, 점유율, 성장 분석 : 제품 유형별, 기술별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Contraceptive Devices Market size was valued at USD 31.83 Billion in 2024 and is poised to grow from USD 33.76 Billion in 2025 to USD 54.05 Billion by 2033, growing at a CAGR of 6.06% during the forecast period (2026-2033).

The contraceptive devices market is set to experience growth driven by initiatives aimed at minimizing unintended pregnancies and healthcare expenditures while increasing user awareness. Various programs led by governments and healthcare organizations advocate for family planning and enhance the production and distribution of contraceptives. Both private and public sectors significantly contribute to the contraceptive supply chain, with the private sector focusing on short-acting methods such as condoms and pills, capturing a substantial market share. In certain regions, a notable percentage of women source contraceptives from private providers, while others depend on public services. Comprehensive campaigns and educational programs targeting younger demographics are crucial for promoting contraceptive use and preventing both STDs and unintended pregnancies, supported by vital contributions from renowned health organizations.

Top-down and bottom-up approaches were used to estimate and validate the size of the Contraceptive Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Contraceptive Devices Market Segments Analysis

Global Contraceptive Devices Market is segmented by product type, technology, distribution channel and region. Based on product type, the market is segmented into male contraceptive devices, female contraceptive devices, female condoms, diaphragms & sponges, vaginal rings, intrauterine devices, sub-dermal implants and others. Based on technology, the market is segmented into hormonal contraceptives and barrier contraceptives. Based on distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, clinics, online channels, public channel & ngo and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Contraceptive Devices Market

A significant advancement in the contraceptive devices market is the introduction of a highly efficient, non-hormonal intrauterine device (IUD). This innovative technology presents women with a dependable and enduring form of birth control. Featuring a unique design that emphasizes safety and user-friendliness, this IUD ensures a seamless contraceptive experience while reducing the likelihood of side effects. Its effectiveness and ease of use position it as an attractive option for women in search of convenient and reliable contraception. This development represents a pivotal shift toward more options in reproductive health, catering to the diverse needs and preferences of women worldwide.

Restraints in the Contraceptive Devices Market

The Contraceptive Devices market faces certain challenges that can hinder its growth potential. Factors such as rising costs, potential complications associated with some devices, and varying regulations across different regions can limit accessibility and consumer adoption. Additionally, cultural stigmas and misinformation surrounding reproductive health may discourage individuals from seeking out these options. Resistance from certain groups, who may view contraceptive use unfavorably, can also impact market acceptance. Furthermore, the availability of alternative birth control methods may lead to increased competition, making it essential for manufacturers to continuously innovate and educate consumers to maintain a strong foothold in the market.

Market Trends of the Contraceptive Devices Market

The Contraceptive Devices market is experiencing significant growth driven by various factors, including rising rates of unintended pregnancies and a growing awareness of family planning methods. Increased prevalence of sexually transmitted infections (STIs) and heightened governmental support for family planning initiatives further catalyze market expansion. The diverse availability of contraceptive options, ranging from condoms to long-acting implants, along with rising disposable incomes, enhances accessibility. Additionally, the surge in e-commerce platforms, development of innovative contraceptive solutions, and a noticeable shift towards non-hormonal and natural methods reflect evolving consumer preferences, particularly towards female-controlled options, effectively propelling the market forward.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Patent Analysis
• Case Study Analysis
• Startup Analysis

Global Contraceptive Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Male Contraceptive Devices
• Female Contraceptive Devices
• Female Condoms, Diaphragms & Sponges
• Vaginal Rings
• Intrauterine Devices
• Sub-Dermal Implants
• Others

Global Contraceptive Devices Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Hormonal Contraceptives
• Barrier Contraceptives

Global Contraceptive Devices Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacy
• Retail Pharmacy
• Clinics
• Online Channels
• Public Channel & Ngo
• Others

Global Contraceptive Devices Market Size & CAGR (2026-2033)

• North America (Product Type, Technology, Distribution Channel)
  • USA
  • Canada
• Europe (Product Type, Technology, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Janssen Global Services, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Sharp & Dohme Corp. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veru Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medisafe Distribution Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Devex (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayer Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agile Therapeutics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HLL Lifecare (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ansell Ltd (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mankind Pharma (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TTK HealthCare (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• V-Care Pharma Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations